163 related articles for article (PubMed ID: 6275778)
1. Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia.
Hargadon MT; Young VM; Schimpff SC; Wade JC; Minah GE
Antimicrob Agents Chemother; 1981 Nov; 20(5):620-4. PubMed ID: 6275778
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
Gurwith M; Truog K; Hinthorn D; Liu C
Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
[TBL] [Abstract][Full Text] [Related]
3. Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression.
Schimpff SC
Ann Intern Med; 1980 Aug; 93(2):358-61. PubMed ID: 7406385
[TBL] [Abstract][Full Text] [Related]
4. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.
Gurwith MJ; Brunton JL; Lank BA; Harding GK; Ronald AR
Am J Med; 1979 Feb; 66(2):248-56. PubMed ID: 371396
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic antimicrobial prophylaxis on microbial flora.
Bodey GP; Rosenbaum B; Valdivieso M; Bolivar R
Antimicrob Agents Chemother; 1982 Mar; 21(3):367-72. PubMed ID: 6285808
[TBL] [Abstract][Full Text] [Related]
6. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
Otis LL; Terezhalmy GT
Oral Surg Oral Med Oral Pathol; 1985 Jul; 60(1):125-9. PubMed ID: 3162130
[TBL] [Abstract][Full Text] [Related]
7. Emergence of resistance as a consequence of antimicrobial prophylaxis in immunocompromised patients.
Dejace P; Klastersky J
Scand J Infect Dis Suppl; 1986; 49():165-71. PubMed ID: 3547622
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
de Jongh CA; Wade JC; Finley RS; Joshi JH; Aisner J; Wiernik PH; Schimpff SC
J Clin Oncol; 1983 May; 1(5):302-7. PubMed ID: 6321684
[TBL] [Abstract][Full Text] [Related]
9. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Kauffman CA; Liepman MK; Bergman AG; Mioduszewski J
Am J Med; 1983 Apr; 74(4):599-607. PubMed ID: 6837588
[No Abstract] [Full Text] [Related]
11. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies.
Gualtieri RJ; Donowitz GR; Kaiser DL; Hess CE; Sande MA
Am J Med; 1983 Jun; 74(6):934-40. PubMed ID: 6407305
[TBL] [Abstract][Full Text] [Related]
12. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
[No Abstract] [Full Text] [Related]
13. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.
de Vries-Hospers HG; Sleijfer DT; Mulder NH; van der Waaij D; Neiweg HO; van Saene HK
Antimicrob Agents Chemother; 1981 May; 19(5):813-20. PubMed ID: 7027923
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial prophylaxis and treatment in patients with granulocytopenia.
Med Lett Drugs Ther; 1981 Jun; 23(12):55-6. PubMed ID: 7242457
[No Abstract] [Full Text] [Related]
15. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
[TBL] [Abstract][Full Text] [Related]
16. Selective decontamination of the digestive tract for the prevention of infection in acute leukemia.
Dekker A; Gaus W; Kurrle E; de Vries-Hospers H; van der Waaij D; Wendt F
Prog Clin Biol Res; 1985; 181():251-3. PubMed ID: 2991943
[No Abstract] [Full Text] [Related]
17. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of infections in granulocytopenia patients with a brulamycin-bactrim combination].
Magyar T; Graber H; Arr M; Csiba A; Kelemen E; Péterfy M; Jánossa M
Orv Hetil; 1985 Sep; 126(35):2165-8. PubMed ID: 3875821
[No Abstract] [Full Text] [Related]
19. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Henry SA
Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
[TBL] [Abstract][Full Text] [Related]
20. [Limitations of selective decontamination of the digestive system in granulopenia patients toward the prevention of infection].
van der Waaij D
Ned Tijdschr Geneeskd; 1985 Jul; 129(27):1268-9. PubMed ID: 3929148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
